1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Ticagrelor Treatment is Associated With Increased Coronary Flow Reserve in Survivors of Myocardial Infarction
(
- Contribution to journal › Article
- 2022
-
Mark
Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction : The phase 2a FLAVOUR study
(
- Contribution to journal › Article
- 2021
-
Mark
Microvesicles in plasma reflect coronary flow reserve in patients with cardiovascular disease
(
- Contribution to journal › Article
- 2020
-
Mark
Design and rationale of FLAVOUR : A phase IIa efficacy study of the 5-lipoxygenase activating protein antagonist AZD5718 in patients with recent myocardial infarction
(
- Contribution to journal › Article
-
Mark
Survival of Patients With Angina Pectoris Undergoing Percutaneous Coronary Intervention With Intracoronary Pressure Wire Guidance
(
- Contribution to journal › Article
- 2019
-
Mark
Prospective evaluation of coronary FLOW reserve and molecular biomarkers in patients with established coronary artery disease the PROFLOW-trial : Cross-sectional evaluation of coronary flow reserve
(
- Contribution to journal › Article
- 2016
-
Mark
Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.
(
- Contribution to journal › Article